Oxytocin Combination Therapy for Sexual Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sexual dysfunction, particularly those involving psychotropic medications and menopausal women, are limited in efficacy and often accompanied by side effects, with a lack of effective therapies for postmenopausal women and males with hypoactive sexual desire.
Innovation Solution
Combination therapy involving oxytocin with other therapeutic agents that modulate the autonomic nervous system, specifically targeting both parasympathetic and sympathetic arms to enhance sexual response, by administering oxytocin intranasally, orally, or topically in conjunction with agents that augment its effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for sexual dysfunction are used, then some therapeutic effect is achieved, but side effects increase and efficacy is limited
Solution Approach 1:
The patent combines oxytocin with other therapeutic agents that modulate the autonomic nervous system to create a synergistic treatment approach. This combination therapy merges the benefits of multiple agents to achieve improved efficacy while potentially reducing the side effects associated with single-agent treatments.
Solution Approach 2:
The patent introduces a novel parameter approach by simultaneously targeting both parasympathetic and sympathetic arms of the autonomic nervous system, rather than focusing on a single pathway. This multi-parameter modulation allows for more precise control of sexual response while minimizing adverse effects.
2Reliability
If single-agent therapies are used, then treatment simplicity is maintained, but therapeutic effectiveness is insufficient
Solution Approach 1:
The patent merges multiple therapeutic agents into a coordinated treatment regimen, combining oxytocin with autonomic nervous system modulators to achieve synergistic effects that overcome the limitations of single-agent therapies.
Solution Approach 2:
The treatment approach is designed to be universally applicable across different populations affected by sexual dysfunction, including postmenopausal women and males with hypoactive sexual desire, by targeting multiple physiological pathways simultaneously.
Data Source
AI summary
The present disclosure describes use of oxytocin, in combination with one or more other agents as described herein, for use for example in the treatment of certain conditions.